Latest News & Features
Americas
UK-based diagnostics company Oxford Immunotec has announced that it will acquire Imugen, a US clinical laboratory, for $22.2 million in cash. 27 June 2016
Big Pharma
The European Patent Office has said that it expects a solution will be found to allow the implementation of the unitary patent despite the referendum result. 24 June 2016
Americas
Teva has settled its patent litigation dispute with AstraZeneca centring on diabetes drug Byetta. 24 June 2016
Big Pharma
The practicalities of litigating disputes were discussed yesterday in the session “Collaboration agreements – What are the best jurisdictions to resolve disputes” at the Life Sciences Law Forum 2016 in London. 24 June 2016
Americas
The US Supreme Court is set to consider today whether to take on a long running patent dispute between Sequenom and Ariosa Diagnostics centring on pre-natal testing. 23 June 2016
Big Pharma
After the “EU Summary of Clinical Trial Results for Laypersons” was published for consultation in June, a counsel from Novo Nordisk discussed the importance of providing reliable information for patients at an industry event in London. 23 June 2016
Americas
A US advisory panel has reportedly approved the use of the CRISPR/Cas9 gene-editing technology on humans for the first time, as part of a study designed to target three types of cancer. 22 June 2016
Asia-Pacific
Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan. 22 June 2016
Americas
The US Supreme Court has invited the solicitor general to file briefs in the Amgen v Sandoz biosimilars case in order to obtain the Obama administration’s view on the dispute between the two companies. 22 June 2016
Big Pharma
A Spain-based pharmaceutical company has applied to trademark ‘Brexit’, the term coined for the UK’s potential departure from the EU. 22 June 2016